• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA FAM83H-AS1 在人卵巢癌中作为潜在的致癌驱动因子发挥作用。

Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.

机构信息

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang District, Harbin, 150081, Hei Longjiang Province, China.

Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, 150081, Hei Longjiang Province, China.

出版信息

J Ovarian Res. 2021 Jan 7;14(1):6. doi: 10.1186/s13048-020-00756-y.

DOI:10.1186/s13048-020-00756-y
PMID:33413565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7792319/
Abstract

OBJECTIVE

Ovarian cancer (OC) is one of the most aggressive women cancers with increasing incidence and mortality rates worldwide. Long non-coding RNAs (lncRNAs) could as major players in OC process. Although FAM83H antisense RNA1 (FAM83H-AS1) is demonstrated play an important roles in a many cancers, the detailed function and mechanism has not been reported in OC.

RESULTS

We integrated multiple kinds of bioinformatics approaches and experiments validated method to evaluate functions of FAM83H-AS1 in OC. Some differential expressed lncRNAs were identified between OC and normal control tissues. FAM83H-AS1 was one of most differentially expressed lncRNAs and up-regulated in multiple cancer types. Specially, expression of FAM83H-AS1 was higher in OC and showed difference in diverse stages. High FAM83H-AS1 expression is associated with worse pan-cancer and OC outcomes. FAM83H-AS1-centric network including lncRNA-miRNA, lncRNA-protein and lncRNA-mRNA ceRNA network were constructed to infer the function and mechanism of FAM83H-AS1. There were two methylation sites including cg01399317 and cg20519035 located at FAM83H-AS1. The methylation level of cg01399317 was correlated with gene expression of FAM83H-AS1. The expression level of FAM83H-AS1 was correlated with infiltration level of immune cell including macrophage, neutrphil and dendritic cell in OC patients. Lastly, qRT-PCR showed that the expression of FAM83H-AS1 was higher in OC tissues than normal control tissues.

CONCLUSION

Collectively, these results indicated that FAM83H-AS1 may act as an oncogenic driver and it may be a potential therapy target in OC.

摘要

目的

卵巢癌(OC)是一种侵袭性最强的女性癌症,全球发病率和死亡率呈上升趋势。长链非编码 RNA(lncRNA)可能是 OC 发生发展过程中的重要调控因子。尽管 FAM83H 反义 RNA1(FAM83H-AS1)在许多癌症中发挥重要作用,但在 OC 中其详细功能和机制尚未报道。

结果

我们综合运用多种生物信息学方法和实验验证方法,评估 FAM83H-AS1 在 OC 中的功能。鉴定出 OC 与正常对照组织之间存在差异表达的 lncRNA。FAM83H-AS1 是差异表达最显著的 lncRNA 之一,在多种癌症类型中上调。特别地,FAM83H-AS1 在 OC 中的表达水平较高,且在不同分期之间存在差异。FAM83H-AS1 高表达与泛癌和 OC 不良预后相关。构建 FAM83H-AS1 为中心的 lncRNA-miRNA、lncRNA-蛋白和 lncRNA-mRNA ceRNA 网络,推断 FAM83H-AS1 的功能和作用机制。FAM83H-AS1 上有两个甲基化位点,包括 cg01399317 和 cg20519035。cg01399317 的甲基化水平与 FAM83H-AS1 的基因表达相关。FAM83H-AS1 的表达水平与 OC 患者中巨噬细胞、中性粒细胞和树突状细胞等免疫细胞的浸润水平相关。最后,qRT-PCR 显示 OC 组织中 FAM83H-AS1 的表达高于正常对照组织。

结论

综上所述,这些结果表明 FAM83H-AS1 可能作为一种癌基因驱动因子,可能成为 OC 的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/fed5d06f4e73/13048_2020_756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/640cf831b035/13048_2020_756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/6d9320189528/13048_2020_756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/b2f36952690d/13048_2020_756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/b42664371712/13048_2020_756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/f76240ff2a61/13048_2020_756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/fed5d06f4e73/13048_2020_756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/640cf831b035/13048_2020_756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/6d9320189528/13048_2020_756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/b2f36952690d/13048_2020_756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/b42664371712/13048_2020_756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/f76240ff2a61/13048_2020_756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3c/7792319/fed5d06f4e73/13048_2020_756_Fig6_HTML.jpg

相似文献

1
Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.长链非编码 RNA FAM83H-AS1 在人卵巢癌中作为潜在的致癌驱动因子发挥作用。
J Ovarian Res. 2021 Jan 7;14(1):6. doi: 10.1186/s13048-020-00756-y.
2
Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.长链非编码RNA FAM83H-AS1在卵巢癌中的临床意义
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4656-4662. doi: 10.26355/eurrev_201906_18045.
3
LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.长链非编码 RNA FAM83H-AS1 通过稳定 HuR 蛋白促进卵巢癌的放射抵抗、增殖和转移。
Eur J Pharmacol. 2019 Jun 5;852:134-141. doi: 10.1016/j.ejphar.2019.03.002. Epub 2019 Mar 2.
4
Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.长链非编码 RNA FAM83H-AS1 在肝细胞癌中的上调通过 Wnt/β-catenin 通路促进细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7855-7862. doi: 10.26355/eurrev_201909_18995.
5
Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).长链非编码 RNA FAM83H-AS1 通过表观遗传沉默 CDKN1A(p21)在胶质瘤中发挥致癌作用。
J Cell Physiol. 2018 Nov;233(11):8896-8907. doi: 10.1002/jcp.26813. Epub 2018 Jun 5.
6
Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis.长链非编码 RNA FAM83H 反义 RNA1(FAM83H-AS1)通过调节 miR-545-3p/硫酸乙酰肝素 6-O-磺基转移酶 2(HS6ST2)轴在非小细胞肺癌进展中的作用。
Bioengineered. 2022 Mar;13(3):6476-6489. doi: 10.1080/21655979.2022.2031668.
7
Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.血清长链非编码 RNA-ATB 和 FAM83H-AS1 作为乳腺癌的诊断/预后无创性生物标志物。
Life Sci. 2020 Oct 15;259:118193. doi: 10.1016/j.lfs.2020.118193. Epub 2020 Aug 5.
8
Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.长链非编码 RNA FAM83H-AS1 受人类乳头瘤病毒 16 E6 调控,而与宫颈癌细胞中的 p53 无关。
Sci Rep. 2019 Mar 6;9(1):3662. doi: 10.1038/s41598-019-40094-8.
9
Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.TMPO-AS1/miRNA-200c/TMEFF2 环状 RNA 网络在卵巢癌细胞恶性行为和 5-FU 耐药中的作用。
Exp Mol Pathol. 2020 Aug;115:104481. doi: 10.1016/j.yexmp.2020.104481. Epub 2020 Jun 1.
10
Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.长链非编码 RNA UBA6-AS1 通过抑制 UBA6 mRNA 的衰减来抑制卵巢癌细胞的恶性转化。
Bioengineered. 2022 Jan;13(1):178-189. doi: 10.1080/21655979.2021.2011640.

引用本文的文献

1
Epithelial characteristics of ovarian clear cell carcinoma at single-cell resolution.单细胞分辨率下卵巢透明细胞癌的上皮特征
Commun Biol. 2025 Aug 5;8(1):1156. doi: 10.1038/s42003-025-08617-4.
2
The emerging roles and mechanisms of FAM83H‑AS1 in cancer: Pathophysiology and therapeutic implications (Review).FAM83H-AS1在癌症中的新兴作用和机制:病理生理学及治疗意义(综述)
Oncol Lett. 2025 Apr 7;29(6):270. doi: 10.3892/ol.2025.15016. eCollection 2025 Jun.
3
Latest Update on lncRNA in Epithelial Ovarian Cancer-A Scoping Review.

本文引用的文献

1
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.长链非编码 RNA 在卵巢癌进展、转移及主要通路中的作用: ceRNA 和替代机制
Int J Mol Sci. 2020 Nov 23;21(22):8855. doi: 10.3390/ijms21228855.
2
Long noncoding RNA: a dazzling dancer in tumor immune microenvironment.长非编码 RNA:肿瘤免疫微环境中的耀眼舞者。
J Exp Clin Cancer Res. 2020 Nov 4;39(1):231. doi: 10.1186/s13046-020-01727-3.
3
LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
上皮性卵巢癌中长链非编码RNA的最新进展——一项综述。
Cells. 2025 Apr 7;14(7):555. doi: 10.3390/cells14070555.
4
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.一种基于甲基化和免疫相关的 lncRNA 特征,用于预测卵巢癌的预后并揭示化疗耐药的机制。
J Ovarian Res. 2023 Sep 6;16(1):186. doi: 10.1186/s13048-023-01260-9.
5
WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.WTAP 参与 lncRNA FAM83H-AS1 的 m6A 修饰加速胃癌的发展。
Mol Biotechnol. 2024 Aug;66(8):1883-1893. doi: 10.1007/s12033-023-00810-2. Epub 2023 Jul 21.
长链非编码 RNA ST8SIA6-AS1 通过 p38 MAPK 信号通路促进乳腺癌的增殖、迁移和侵袭。
Carcinogenesis. 2020 Sep 24;41(9):1273-1281. doi: 10.1093/carcin/bgz197.
4
A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia.一个长链非编码 RNA 与 Ezh2 协同抑制 HIF-1α 的转录,从而抑制肿瘤细胞对低氧的适应。
Oncogene. 2020 Feb;39(9):1860-1874. doi: 10.1038/s41388-019-1123-9. Epub 2019 Nov 29.
5
Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer.长链非编码 RNA LCAT1 通过海绵吸附 miR-4715-5p 来调控 RAC1 功能,从而在肺癌中发挥 ceRNA 作用。
Mol Cancer. 2019 Nov 29;18(1):171. doi: 10.1186/s12943-019-1107-y.
6
DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts.DIANA-LncBase v3:在非编码转录本上索引实验支持的 miRNA 靶标。
Nucleic Acids Res. 2020 Jan 8;48(D1):D101-D110. doi: 10.1093/nar/gkz1036.
7
Knockdown of long non-coding RNA LINC00176 suppresses ovarian cancer progression by BCL3-mediated down-regulation of ceruloplasmin.敲低长链非编码 RNA LINC00176 通过 BCL3 介导的下调铜蓝蛋白抑制卵巢癌细胞进展。
J Cell Mol Med. 2020 Jan;24(1):202-213. doi: 10.1111/jcmm.14701. Epub 2019 Oct 30.
8
FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer.FAM83H-AS1 上调并预测结肠癌预后不良。
Biomed Pharmacother. 2019 Oct;118:109342. doi: 10.1016/j.biopha.2019.109342. Epub 2019 Aug 19.
9
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.肌肉减少症与卵巢癌生存:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1165-1174. doi: 10.1002/jcsm.12468. Epub 2019 Aug 7.
10
miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.miR-211 通过阻断卵巢癌细胞中的 DNA 损伤反应(DDR)促进铂类化疗敏感性。
Cell Death Dis. 2019 Jun 24;10(7):495. doi: 10.1038/s41419-019-1715-x.